DDInter1168 DDInter1180
Methdilazine is a phenothiazine compound with antihistaminic activity. It is used in the treatment of various dermatoses to relieve pruritus.
Methscopolamine is a quaternary ammonium derivative of scopolamine and antagonist at muscarininc (mACh) receptors. Methscopolamine bromide is the most common form of the active ingredient in oral pharmaceutical products. The oral tablets are used as an adjunct therapy for the treatment of peptic ulcer and is shown to be effective in decreasing the rate of recurrence of peptic ulcers as well as preventing complications.
Methdilazine {u} (Compound) resembles {v} (Compound) Thioproperazine
Methdilazine {u} (Compound) resembles {v} (Compound) Epinastine
Methdilazine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Cyproheptadine
Methdilazine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Promethazine
Methdilazine {u} (Compound) binds {v} (Gene) HRH1
Methdilazine {u} may cause a minor interaction that can limit clinical effects when taken with {v} Magnesium hydroxide
Methdilazine {u} may cause a minor interaction that can limit clinical effects when taken with {v} Sucralfate
Methdilazine {u} may lead to a major life threatening interaction when taken with {v} Dextropropoxyphene
Methdilazine {u} may lead to a major life threatening interaction when taken with {v} Deutetrabenazine
Methdilazine {u} (Compound) resembles {v} (Compound) and {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Perphenazine
Methdilazine (Compound) resembles Thioproperazine (Compound)
Methdilazine (Compound) resembles Epinastine (Compound)
Methdilazine may cause a moderate interaction that could exacerbate diseases when taken with Cyproheptadine
Methdilazine may cause a moderate interaction that could exacerbate diseases when taken with Promethazine
Methdilazine (Compound) binds HRH1 (Gene)
Methdilazine may cause a minor interaction that can limit clinical effects when taken with Magnesium hydroxide
Methdilazine may cause a minor interaction that can limit clinical effects when taken with Sucralfate
Methdilazine may lead to a major life threatening interaction when taken with Dextropropoxyphene
Methdilazine may lead to a major life threatening interaction when taken with Deutetrabenazine
Methdilazine (Compound) resembles Perphenazine (Compound) and Methdilazine may cause a moderate interaction that could exacerbate diseases when taken with Perphenazine